A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Explore this paper's citation graph
Summary
This simple, novel bleeding risk score (HAS-BLED) provides a practical tool to assess the individual bleeding risk of real-world patients withAF, potentially supporting clinical decision making regarding antithrombotic therapy in patients with AF.
- Type
- article
- Published
- 2010-11-01
- Cited by
- 4,523
- References
- 28
- Access
- Open access
- OpenAlex
- https://openalex.org/W2127985968
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:207385347
Keywords
Medicine, Atrial fibrillation, Cohort, Framingham Risk Score, Internal medicine
References
- Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
- Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
- Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
- Physician variation in the management of patients with atrial fibrillation.
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
- The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
- Clinical Features and Functional Outcome of Intracerebral Hemorrhage in Patients Aged 85 and Older
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
- Altered platelet plug formation in hyperthyroidism and hypothyroidism.
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators
- Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.
- Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.
- Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
- Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).
- Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.
- Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
- Dabigatran versus warfarin in patients with atrial fibrillation.
Cited by
- Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
- Patientenauswahl für die Implantation eines Vorhofohr-Okkluders in der Primär- und Sekundärprävention des kardioembolischen Schlaganfalls bei Vorhofflimmern
- The risk of bleeding with anticoagulant treatments
- The Experience of Primary Healthcare patients who take Warfarin in New Zealand
- Atrial fibrillation: state of the art
- The prevalence of atrial fibrillation in a geographically well‐defined population in Northern Sweden: implications for anticoagulation prophylaxis
- The effectiveness and safety of fixed low‐dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin (CME)
- Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation.
- Atrial fibrillation and congestive heart failure.
- Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.
- Safety of dronedarone in routine clinical care.
- The management of atrial fibrillation: summary of updated NICE guidance
- Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
- Determinants of the Over-Anticoagulation Response during Warfarin Initiation Therapy in Asian Patients Based on Population Pharmacokinetic-Pharmacodynamic Analyses
- The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- Truly low and high thromboembolic risk – impact of risk scores in real life
- Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis.
- Triple Antithrombotic Therapy in Atrial Fibrillation Patients With an Indication for Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A Case-Based Review of the Current Evidence
- Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
Related papers
- Experimental antithrombotic effect of potatoes harvested in the autumn
- Antithrombotic Therapy: Focus on the Elderly
- Novel antithrombotic therapy.
- [Antithrombotic therapy in the elderly - are there differences?]
- Antithrombotic therapy in atrial fibrillation.
- Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective
- Long-term exposure to PM2.5 and stroke: A systematic review and meta-analysis of cohort studies.
- Long-Term Management of Blood Pressure after Stroke
- Long-term Management of Blood Pressure after Stroke